What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Dukers Muijrers, Nicole H T M ^a,b   Schachter, Julius ^c   van Liere, Genevieve A F S ^a,b   Wolffs, Petra F G ^b   Hoebe, Christian J P A ^a,b  

^a Public Health Services   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia trachomatis; Extra genital; MSM; Neisseria gonorrhoeae; Women

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ANORECTAL INFECTION; ARTICLE; BACTERIAL LOAD; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GONORRHEA; HUMAN; MEN WHO HAVE SEX WITH MEN; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PHARYNGITIS; PRACTICE GUIDELINE; RECTUM DISEASE; THROAT CULTURE; CHLAMYDIA INFECTIONS; COST BENEFIT ANALYSIS; FEMALE; MALE; MALE HOMOSEXUALITY; MICROBIOLOGY; MYCOPLASMA GENITALIUM; PATHOGENICITY; PHARYNGEAL DISEASES; PHARYNX; RECTAL DISEASES; RECTUM; SEXUAL BEHAVIOR; SEXUALITY;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; FEMALE; GONORRHEA; GUIDELINES AS TOPIC; HOMOSEXUALITY, MALE; HUMANS; MALE; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; PHARYNGEAL DISEASES; PHARYNX; RECTAL DISEASES; RECTUM; SEXUAL BEHAVIOR; SEXUAL PARTNERS;

EID: 84947434172     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1280-6     Document Type: Article

References (91)

1. Price MJ, Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178(3):484-92. doi: 10.1093/aje/kws583. Epub 2013 Jun 27.
2. Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am. 2013;27(4):793-809. doi: 10.1016/j.idc.2013.08.004. Epub 2013 Oct 31.
3. Centers for Disease Control and Prevention. 2013 Sexually Transmitted Diseases Surveillance: http://www.cdc.gov/std/stats13/chlamydia.htm (last accessed 8 June 2015)
4. European Centre for Disease Prevention and Control. Chlamydia control in Europe: literature review. Stockholm: ECDC; 2014.
5. Sexually transmitted diseases treatment guidelines, 2015, Workowski KA, Bolan GA. Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2015;64(RR3):1-137.
6. British Association for Sexual Health and HIV (BASHH) (2010) Chlamydia trachomatis UK Testing Guidelines. Clinical Effectiveness Group. 2010 Update to Chlamydia testing. Available: http://www.bashh.org/documents/3352.pdf and http://www.bashh.org/guidelines (Last accessed 2015 June 01) and 2014 Draft UK national guideline for the management of genital infection with Chlamydia trachomatis
7. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014;63(RR-02):1-19.
8. Australian STI management guidelines for use in primary care. http://www.sti.guidelines.org.au/sexually-transmissible-infections/chlamydia#diagnosis (Last accessed 2015 June 01.)
9. de Vries HJC, van Doornum GJJ, Bax CJ. Multidisciplinaire Richtlijn Seksueel Overdraagbare Aandoeningen voor de 2e Lijn, Nederlandse Vereniging voor Dermatologie en Venereologie. 2012. p. 1-151.
10. van Liere GA, Hoebe CJ, Wolffs PF, Dukers-Muijrers NH. High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women. BMC Infect Dis. 2014;14:274. doi: 10.1186/1471-2334-14-274.
11. van Liere GA, Hoebe CJ, Niekamp AM, Koedijk FD, Dukers-Muijrers NH. Standard symptom- and sexual history-based testing misses anorectal Chlamydia trachomatis and neisseria gonorrhoeae infections in swingers and men who have sex with men. Sex Transm Dis. 2013;40(4):285-9. doi: 10.1097/OLQ.0b013e31828098f8.
12. Peters RP, Dubbink JH, van der Eem L, Verweij SP, Bos ML, Ouburg S, et al. Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa. Sex Transm Dis. 2014;41(9):564-9. doi: 10.1097/OLQ.0000000000000175.
13. Bazan JA, Carr Reese P, Esber A, Lahey S, Ervin M, Davis JA, et al. High prevalence of rectal gonorrhea and Chlamydia infection in women attending a sexually transmitted disease clinic. J Womens Health (Larchmt). 2015;24(3):182-9. doi: 10.1089/jwh.2014.4948. Epub 2015 Feb 18.
14. Ladd J, Hsieh YH, Barnes M, Quinn N, Jett-Goheen M, Gaydos CA. Female users of internet-based screening for rectal STIs: descriptive statistics and correlates of positivity. Sex Transm Infect. 2014;90(6):485-90. doi: 10.1136/sextrans-2013-051167. Epub 2014 Mar 6.
15. Garner AL, Schembri G, Cullen T, Lee V. Should we screen heterosexuals for extra-genital chlamydial and gonococcal infections? Int J STD Aids. 2014.
16. Hunte T, Alcaide M, Castro J. Rectal infections with chlamydia and gonorrhoea in women attending a multiethnic sexually transmitted diseases urban clinic. Int J STD AIDS. 2010;21(12):819-22. doi: 10.1258/ijsa.2010.009279.
17. Javanbakht M, Gorbach P, Stirland A, Chien M, Kerndt P, Guerry S. Prevalence and correlates of rectal Chlamydia and gonorrhea among female clients at sexually transmitted disease clinics. Sex Transm Dis. 2012;39(12):917-22. doi: 10.1097/OLQ.0b013e31826ae9a2.
18. Koedijk FD, van Bergen JE, Dukers-Muijrers NH, van Leeuwen AP, Hoebe CJ, van der Sande MA, et al. The value of testing multiple anatomic sites for gonorrhoea and chlamydia in sexually transmitted infection centres in the Netherlands, 2006-2010. Int J STD AIDS. 2012;23(9):626-31. doi: 10.1258/ijsa.2012.011378.
19. Sethupathi M, Blackwell A, Davies H. Rectal Chlamydia trachomatis infection in women. Is it overlooked? Int J STD AIDS. 2010;21(2):93-5. doi: 10.1258/ijsa.2008.008406.
20. Barry PM, Kent CK, Philip SS, Klausner JD. Results of a program to test women for rectal chlamydia and gonorrhea. Obstet Gynecol. 2010;115(4):753-9.
21. Gratrix J, Singh AE, Bergman J, Egan C, Plitt SS, McGinnis J, et al. Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis. 2015;60(3):398-404. doi: 10.1093/cid/ciu831.
22. Peters RP, Nijsten N, Mutsaers J, Jansen CL, Morré SA, van Leeuwen AP. Screening of oropharynx and anorectum increases prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in female STD clinic visitors. Sex Transm Dis. 2011;38(9):783-7. doi: 10.1097/OLQ.0b013e31821890e9.
23. Shaw SG, Hassan-Ibrahim M, Soni S. Are we missing pharyngeal and rectal infections in women by not testing those who report oral and anal sex? Sex Transm Infect. 2013;89(5):397. doi: 10.1136/sextrans-2013-051159.
24. Bachmann LH, Johnson RE, Cheng H, Markowitz L, Papp JR, Palella Jr FJ, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol. 2010;48(5):1827-32. doi: 10.1128/JCM.02398-09. Epub 2010 Mar 24.
25. van der Helm JJ, Hoebe CJ, van Rooijen MS, Brouwers EE, Fennema HS, Thiesbrummel HF, et al. High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex Transm Dis. 2009;36(8):493-7. doi: 10.1097/OLQ.0b013e3181a44b8c.
26. Ding A, Challenor R. Rectal Chlamydia in heterosexual women: more questions than answers. Int J STD AIDS. 2013;25(8):587-92 [Epub ahead of print].
27. Ostergaard L, Agner T, Krarup E, Johansen UB, Weismann K, Gutschik E. PCR for detection of Chlamydia trachomatis in endocervical, urethral, rectal, and pharyngeal swab samples obtained from patients attending an STD clinic. Genitourin Med. 1997;73(6):493-7.
28. Trebach JD, Chaulk CP, Page KR, Tuddenham S, Ghanem KG. Neisseria gonorrhoeae and Chlamydia trachomatis Among Women Reporting Extra-genital Exposures. Sex Transm Dis. 2015;42(5):233-9. doi: 10.1097/OLQ.0000000000000248.
29. Cosentino LA, Campbell T, Jett A, Macio I, Zamborsky T, Cranston RD, et al. Use of Nucleic Acid Amplification Testing for Diagnosis of Anorectal Sexually Transmitted Infections. J Clin Microbiol. 2012;50(6):2005-8. doi: 10.1128/JCM.00185-12 PMCID: PMC3372150.
30. Musil K, Currie M, Sherley M, Martin S. Rectal chlamydia infection in women at high risk of chlamydia attending Canberra Sexual Health Centre. Int J STD Aids. 2015.
31. Dukers-Muijrers NH, Theunissen KA, Wolffs PT, Kok G, Hoebe CJ. Acceptance of Home-Based Chlamydia Genital and Anorectal Testing Using Short Message Service (SMS) in Previously Tested Young People and Their Social and Sexual Networks. PLoS ONE. 2015;10(7):e0133575. doi: 10.1371/journal.pone.0133575. eCollection 2015.
32. van Rooijen MS, Schim van der Loeff MF, Morré SA, van Dam AP, Speksnijder AG, de Vries HJ. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sex Transm Infect. 2014. doi: 10.1136/sextrans-2014-051633. [Epub ahead of print]
33. Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67-74. Epub 2005 May 26.
34. Patton ME, Kidd S, Llata E, Stenger M, Braxton J, Asbel L, et al. Extra-genital gonorrhea and chlamydia testing and infection among men who have sex with men-STD Surveillance Network, United States, 2010-2012. Clin Infect Dis. 2014;58(11):1564-70. doi: 10.1093/cid/ciu184. Epub 2014 Mar 18.
35. Ivens D, Macdonald K, Bansi L, Nori A. Screening for rectal chlamydia infection in a genitourinary medicine clinic. Int J STD AIDS. 2007;18(6):404-6.
36. Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U, et al. Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect. 2014;90(1):46-51. doi: 10.1136/sextrans-2012-050929. Epub 2013 Aug 6.
37. Chow EP, Tomnay J, Fehler G, Whiley D, Read TR, Denham I, et al. Substantial increases in chlamydia and gonorrhea positivity unexplained by changes in individual-level sexual behaviors among men who have sex with men in an Australian sexual health service from 2007 to 2013. Sex Transm Dis. 2015;42(2):81-7. doi: 10.1097/OLQ.0000000000000232.
38. Marcus U, Ort J, Grenz M, Eckstein K, Wirtz K, Wille A. Risk factors for HIV and STI diagnosis in a community-based HIV/STI testing and counselling site for men having sex with men (MSM) in a large German city in 2011-2012. BMC Infect Dis. 2015;15(1):14 [Epub ahead of print].
39. Park J, Marcus JL, Pandori M, Snell A, Philip SS, Bernstein KT. Sentinel surveillance for pharyngeal chlamydia and gonorrhea among men who have sex with men-San Francisco, 2010. Sex Transm Dis. 2012;39(6):482-4. doi: 10.1097/OLQ.0b013e3182495e2f.
40. Haar K, Dudareva-Vizule S, Wisplinghoff H, Wisplinghoff F, Sailer A, Jansen K, et al. Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, Germany. Emerg Infect Dis. 2013;19(3):488-92. doi: 10.3201/eid1903.121028.
41. de Vrieze NH, van Rooijen M, Speksnijder AG, de Vries HJ. Urethral lymphogranuloma venereum infections in men with anorectal lymphogranuloma venereum and their partners: the missing link in the current epidemic? Sex Transm Dis. 2013;40(8):607-8. doi: 10.1097/01.OLQ.0000431359.26583.13.
42. Verweij SP, Ouburg S, de Vries H, Morré SA, van Ginkel CJ, Bos H, et al. The first case record of a female patient with bubonic lymphogranuloma venereum (LGV), serovariant L2b. Sex Transm Infect. 2012;88(5):346-7. doi: 10.1136/sextrans-2011-050298.
43. van Liere GA, Hoebe CJ, Dukers-Muijrers NH. Evaluation of the anatomical site distribution of chlamydia and gonorrhoea in men who have sex with men and in high-risk women by routine testing: cross-sectional study revealing missed opportunities for treatment strategies. Sex Transm Infect. 2014;90(1):58-60. doi: 10.1136/sextrans-2013-051248. Epub 2013 Oct 8.
44. Templeton DJ, Jin F, McNally LP, Imrie JC, Prestage GP, Donovan B, et al. Prevalence, incidence and risk factors for pharyngeal gonorrhoea in a community-based HIV-negative cohort of homosexual men in Sydney, Australia. Sex Transm Infect. 2010;86(2):90-6. doi: 10.1136/sti.2009.036814. Epub 2009 Oct 19.
45. Ota KV, Fisman DN, Tamari IE, Smieja M, Ng LK, Jones KE, et al. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study. Clin Infect Dis. 2009;48(9):1237-43. doi: 10.1086/597586.
46. Tipple C, Hill SC, Smith A. Is screening for pharyngeal Chlamydia trachomatis warranted in high-risk groups? Int J STD AIDS. 2010;21(11):770-1. doi: 10.1258/ijsa.2010.009494.
47. Manavi K, Zafar F, Shahid H. Oropharyngeal gonorrhoea: rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome. Int J STD AIDS. 2010;21(2):138-40. doi: 10.1258/ijsa.2009.009167. Epub 2009 Nov 2.
48. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis. 2008;35(7):637-42. doi: 10.1097/OLQ.0b013e31817bdd7e.
49. Moncada J, Schachter J, Liska S, Shayevich C, Klausner JD. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol. 2009;47(6):1657-62. doi: 10.1128/JCM.02269-08. Epub 2009 Apr 15.
50. Schachter J, Philip SS. Testing men who have sex with men for urethral infection with Chlamydia trachomatis and Neisseria gonorrhoeae is only half the job, and we need the right tools. Sex Transm Dis. 2011;38(10):925-7. doi: 10.1097/OLQ.0b013e318230f3d6.
51. Dimech W, Lim MS, Van Gemert C, Guy R, Boyle D, ACCESS collaboration, et al. Analysis of laboratory testing results collected in an enhanced chlamydia surveillance system in Australia, 2008-2010. BMC Infect Dis. 2014;14:325. doi: 10.1186/1471-2334-14-325.
52. den Heijer CD, van Liere GA, Hoebe CJ, van Bergen JE, Cals JW, Stals FS et al. NH. Who tests whom? A comprehensive overview of Chlamydia trachomatis test practices in a Dutch region among different STI care providers for urogenital, anorectal and oropharyngeal sites in young people: a cross-sectional study. Sex Transm Infect. 2015. doi: 10.1136/sextrans-2015-052065.
53. McMillan A, Kell P, Ward H. British Co-operative Clinical Group of British Association for Sexual Health and HIV Diagnosing chlamydia and managing proctitis in men who have sex with men: current UK practice. Sex Transm Infect. 2008;84(2):97-100. Epub 2007 Dec 12.
54. Mercer CH, Tanton C, Prah P, Erens B, Sonnenberg P, Clifton S, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1781-94. doi: 10.1016/S0140-6736(13)62035-8. Epub 2013 Nov 26.
55. de Vries HJ, Zingoni A, White JA, Ross JD, Kreuter A, de Vries HJ, et al. 2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS. 2013;25(7):465-74 [Epub ahead of print].
56. Chan SY, Jose S, King R, Pakianathan MR, Sabin C, Sadiq ST, et al. How likely is environmental or patient cross-contamination of Chlamydia trachomatis DNA to lead to false positive results in patients attending our clinic? Sex Transm Infect. 2013;89(2):105-7. doi: 10.1136/sextrans-2012-050667. Epub 2012 Oct 4.
57. Yeruva L, Spencer N, Bowlin AK, Wang Y, Rank RG. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. Pathog Dis. 2013;68(3):88-95. doi: 10.1111/2049-632X.12052. Epub 2013 Jul 10.
58. Rank RG, Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun. 2014;82(4):1362-71. doi: 10.1128/IAI.01244-13. Epub 2014 Jan 13. Review.
59. Schachter J, Grossman M, Holt J, Sweet R, Spector S. Infection with Chlamydia trachomatis: involvement of multiple anatomic sites in neonates. J Infect Dis. 1979;139(2):232-4.
60. Bissessor M, Tabrizi SN, Fairley CK, Danielewski J, Whitton B, Bird S, et al. Differing Neisseria gonorrhoeae bacterial loads in the pharynx and rectum in men who have sex with men: implications for gonococcal detection, transmission, and control. J Clin Microbiol. 2011;49(12):4304-6. doi: 10.1128/JCM.05341-11. Epub 2011 Sep 28.
61. Kong FY, Tabrizi SN, Fairley CK, Vodstrcil LA, Huston WM, Chen M et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. J Antimicrob Chemother. 2015. [Epub ahead of print]
62. Hocking JS, Kong FY, Timms P, Huston WM, Tabrizi SN. Treatment of rectal chlamydia infection may be more complicated than we originally thought. J Antimicrob Chemother. 2015;70(4):961-4. doi: 10.1093/jac/dku493. Epub 2014 Dec 4.
63. Jordan SJ, Geisler WM. Azithromycin for rectal chlamydia: is it time to leave azithromycin on the shelf?...Not yet. Sex Transm Dis. 2014;41(2):86-8. doi: 10.1097/OLQ.0000000000000092.
64. Senior K. Chlamydia: a much underestimated STI. Lancet Infect Dis. 2012;12(7):517-8.
65. Odesanmi TY, Wasti SP, Odesanmi OS, Adegbola O, Oguntuase OO, Mahmood S. Comparative effectiveness and acceptability of home-based and clinic-based sampling methods for sexually transmissible infections screening in females aged 14-50 years: a systematic review and meta-analysis. Sex Health. 2013;10(6):559-69. doi: 10.1071/SH13029.
66. Theunissen KA, Hoebe CJ, Crutzen R, Kara-Zaïtri C, de Vries NK, van Bergen JE, et al. Using intervention mapping for the development of a targeted secure web-based outreach strategy named SafeFriend, for Chlamydia trachomatis testing in young people at risk. BMC Public Health. 2013;13:996. doi: 10.1186/1471-2458-13-996.
67. Khosropour CM, Manhart LE, Colombara DV, Gillespie CW, Lowens MS, Totten PA, et al. Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study. Sex Transm Infect. 2014;90(1):3-7. doi: 10.1136/sextrans-2013-051174. Epub 2013 Oct 8.
68. Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM. Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea. PLoS Med. 2014;11(2):e1001598. doi: 10.1371/journal.pmed.1001598. eCollection 2014.
69. Barbee LA. Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis. 2014;27(3):282-7. doi: 10.1097/QCO.0000000000000058.
70. Xiridou M, Soetens LC, Koedijk FD, Van der Sande MA, Wallinga J. Public health measures to control the spread of antimicrobial resistance in Neisseria gonorrhoeae in men who have sex with men. Epidemiol Infect. 2015;143(8):1575-84. doi: 10.1017/S0950268814002519. Epub 2014 Oct 2.
71. Kohlhoff SA, Hammerschlag MR. Treatment of Chlamydial infections: 2014 update. Expert Opin Pharmacother. 2015;16(2):205-12. doi: 10.1517/14656566.2015.999041.
72. Christiansen MT, Brown AC, Kundu S, Tutill HJ, Williams R, Brown JR, et al. Whole-genome enrichment and sequencing of Chlamydia trachomatis directly from clinical samples. BMC Infect Dis. 2014;14(1):591 [Epub ahead of print].
73. Althaus CL, Turner KM, Mercer CH, Auguste P, Roberts TE, Bell G, et al. Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling. Health Technol Assess. 2014;18(2):1-100. doi: 10.3310/hta18020. vii-viii.
74. Dukers-Muijrers NH, Morré SA, Speksnijder A, van der Sande MA, Hoebe CJ. Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. PLoS ONE. 2012;7(3):e34108. doi: 10.1371/journal.pone.0034108. Epub 2012 Mar 28.
75. Dukers-Muijrers NH, Speksnijder AG, Morré SA, Wolffs PF, van der Sande MA, Brink AA, et al. Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms. PLoS ONE. 2013;8(11):e81236. doi: 10.1371/journal.pone.0081236. eCollection 2013.
76. Craig AP, Kong FY, Yeruva L, Hocking JS, Rank RG, Wilson DP, et al. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract. BMC Infect Dis. 2015;15(1):200. doi: 10.1186/s12879-015-0939-3.
77. Bernstein KT, Stephens SC, Barry PM, Kohn R, Philip SS, Liska S, et al. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clin Infect Dis. 2009;49(12):1793-7. doi: 10.1086/648427.
78. Marcus JL, Kohn RP, Barry PM, Philip SS, Bernstein KT. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Sex Transm Dis. 2011;38(5):372-3. doi: 10.1097/OLQ.0b013e3182029008.
79. Hui B, Fairley CK, Chen M, Grulich A, Hocking J, Prestage G et al. Oral and anal sex are key to sustaining gonorrhoea at endemic levels in MSM populations: a mathematical model. Sex Transm Infect. 2015. doi: 10.1136/sextrans-2014-051760. [Epub ahead of print]
80. Vodstrcil LA, McIver R, Huston WM, Tabrizi SN, Timms P, Hocking JS. The epidemiology of chlamydia trachomatis organism load during genital infection: A systematic review. J Infect Dis. 2014. [Epub ahead of print]
81. Dirks JA, Wolffs PF, Dukers-Muijrers NH, Brink AA, Speksnijder AG, Hoebe CJ. Chlamydia trachomatis Load in Population-Based Screening and STI-Clinics: Implications for Screening Policy. PLoS ONE. 2015;10(3):e0121433. doi: 10.1371/journal.pone.0121433.
82. Van Liere GAFS, Dirks JA, Hoebe JPA, Wolffs P, Dukers-Muijrers NHTM. Anorectal chlamydia load is similar in men who have sex with men and women reporting anal sex. PLoS ONE. 2015;10(8):e0134991. doi: 10.1371/journal.pone.0134991. eCollection 2015.
83. Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2010;53(4):537-43.
84. Jin F, Prestage GP, Imrie J, Kippax SC, Donovan B, Templeton DJ, et al. Anal sexually transmitted infections and risk of HIV infection in homosexual men. J Acquir Immune Defic Syndr. 2010;53(1):144-9.
85. Pathela P, Braunstein SL, Blank S, Schillinger JA. HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry. Clin Infect Dis. 2013;57(8):1203-9.
86. Vaughan AS, Kelley CF, Luisi N, Del Rio C, Sullivan PS, Rosenberg ES. An application of propensity score weighting to quantify the causal effect of rectal sexually transmitted infections on incident HIV among men who have sex with men. BMC Med Res Methodol. 2015;15(1):25. doi: 10.1186/s12874-015-0017-y.
87. Chesson HW, Bernstein KT, Gift TL, Marcus JL, Pipkin S, Kent CK. The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV Infection. Sex Transm Dis. 2013;40(5):366-71. doi: 10.1097/OLQ.0b013e318284e544.
88. Vriend HJ, Lugnér AK, Xiridou M, van der Loeff MF S, Prins M, de Vries HJ, et al. Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective. AIDS. 2013;27(14):2281-90. doi: 10.1097/QAD.0b013e32836281ee.
89. Hessol NA, Holly EA, Efird JT, Minkoff H, Weber KM, Darragh TM, et al. Concomitant anal and cervical human papillomavirus infections and intraepithelial neoplasia in HIV-infected and uninfected women. AIDS. 2013;27(11):1743-51. doi: 10.1097/QAD.0b013e3283601b09.
90. McGowin CL, Anderson-Smits C. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog. 2011;7(5):e1001324. doi: 10.1371/journal.ppat.1001324. Epub 2011 May 26.
91. Lillis RA, Nsuami MJ, Myers L, Martin DH. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol. 2011;49:1990-2.